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background: Decongestion strategies in acute heart failure (AHF) have been posited to result in varying degrees of renin-angiotensin-aldosterone 
system (RAAS) activation. The association between the degree of RAAS activation and outcomes after AHF is unknown.
Methods: We analyzed 427 AHF patients enrolled in DOSE and CARRESS. We assessed the relationship between the change in RAAS biomarkers-
-plasma renin activity (PRA), aldosterone (aldo)--from baseline (BL) to 72-96h and decongestion strategy. Comparisons were high vs. low-dose and 
continuous infusion vs. bolus furosemide for DOSE and ultrafiltration (UF) vs. stepped pharmacologic (pharm) care for CARRESS. We determined the 
relationship between BL RAAS biomarkers and 60-day death/HF hospitalization (hosp).
results: Patients with RAAS ≥ median had lower blood pressures and serum sodium, and higher BUN. Continuous infusion and UF were associated 
with greater increases in PRA (Table). There was no significant difference in RAAS biomarker change with high vs. low-dose diuretics. Baseline log aldo 
was associated with increased death/HF hosp (HR 1.18; 95% CI: 1.05-1.33). Baseline log PRA was not associated with increased death/HF hosp 
(HR 1.05; 95% CI: 0.99-1.12).
conclusions: Contrary to traditional dogma, high dose loop diuretics did not result in greater RAAS activation than low dose. UF resulted in greater 
PRA increase than stepped pharm care. Baseline aldo, but not PRA, was associated with worse outcomes.
